Axel Wiest: Translating Ideas into Therapies-Opportunities & Challenges of Biopharma, Research & Development

Academia meets Industry

A Political-Scientific Discussion

Dr. Axel Wiest serves as VP, R&D Strategy & Planning at Bristol Myers
Squibb. His prior roles and responsibilities include SVP, R&D Strategy
and Business Operations and COO R&D at Merck Healthcare
KGaA/EMD Serono (2014-2019); VP, Strategy and Project Management
at Boehringer Ingelheim Biopharmaceuticals (2009-2013); and EVP/COO
at Fresenius Biotech GmbH and President of Fresenius Biotech North
America Inc. (2002-2009). Prior he served as a management consultant
at A.T. Kearney, as a resident physician in Germany and Colombia, and
as a consultant for WHO. He holds an M.D./Ph.D. from the University of
Freiburg and Heidelberg and the German Cancer Research Center as
well as a Master of Public Health from the Johns Hopkins School of
Public Health.

The seminar series “Academia meets Industry” aims at stimulating
interdisciplinary discussions between university members and high profile
managers from industry and public health organizations. It addresses the
complex challenges in science, management, politics and society which
are promoted by both university and industry in a concerted action. At
these seminars the practical perspective of the guest speakers
encounters the education and research priorities of the university and
thus allows an unprecedented dialogue on chances and risks of current
and future research developments in life sciences.

Host

Thomas Stieglitz

PDF